NewsRx

Search our medical news database

Crowell & Moring Llp

Crowell & Moring Adds Antitrust and Securities Litigation Partner Daniel Edelman in New York

Published in Health Business Week, January 23rd, 2009

Crowell & Moring LLP is pleased to announce the addition of partner Daniel D. Edelman to the firm's Commercial Litigation Group in New York. A seasoned litigator with extensive experience representing clients in antitrust and securities cases, Edelman's move enhances Crowell & Moring's ongoing work in sophisticated class action lawsuits and other high-profile litigation. Edelman joins from Heller Ehrman LLP, where he was a shareholder.

"Dan has counseled clients through high-stakes litigation and is adept at integrating both the civil and criminal components in formulating his approach to cases. He is the perfect addition to our New York office, which has gained a...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook